LARA MMMA Public Meeting 5-4-18

LARA MMMA Public Meeting 5-4-18

Medical Marihuana Review Panel

May 4, 2018 – 9:00 a.m.

Location:
Williams Building 1st Floor Auditorium
525 W Ottawa St, Lansing, MI 48933

AGENDA

The public hearing is for the Medical Marihuana Review Panel (Review Panel) to review
petitions to include a particular medical condition or treatment to the list of debilitating
medical conditions pursuant to the Michigan Medical Marihuana Act, 2008 IL 1, MCL
333.26421 to 333.26430 (MMMA).

The petitions submitted to the Review Panel under the MMMA are as follows: anxiety,
depression, obsessive compulsive disorder, panic attacks, schizophrenia, social anxiety
disorder, arthritis, rheumatoid arthritis, brain injury, spinal cord injury, asthma, diabetes,
colitis, gastric ulcer, inflammatory bowel disease, ulcerative colitis, organ transplant, non severe and non-chronic pain, Parkinson’s, Tourette’s syndrome, autism, and chronic pain.

And any other business properly before the Review Panel.

The meeting site and parking are accessible. To enhance accessibility for everyone, individuals attending the meeting
are requested to refrain from using heavily scented personal care products. People with disabilities requiring additional
accommodations to participate in the meeting should call Kelly Kronner at (517) 284-8584. LARA is an equal
opportunity employer/program.

LARA MMMA Public Meeting 5-4-18

LARA MMMA Public Meeting 4-27-18

This public hearing is to allow citizens to offer comments related to the filing of a petition to include a particular medical condition or treatment to the list of debilitating medical conditions identified in MCL 333.26423(b).

The petitions submitted to the Medical Marihuana Review Panel (Review Panel) under the Michigan Medical Marihuana Act, 2008 IL

1, MCL 333.26421 to 333.26430 (MMMA) are as follows:

anxiety, depression, obsessive compulsive disorder, panic attacks, schizophrenia, social anxiety disorder, arthritis, rheumatoid arthritis, brain injury, spinal cord injury, asthma, diabetes, colitis, gastric ulcer, inflammatory bowel disease, ulcerative colitis, organ transplant, non-severe and non-chronic pain, Parkinson’s, Tourette’s syndrome, autism, and chronic pain.

Public comments on the petitions may be presented in person at the public hearing or emailed up until 5:00 p.m. on May 3, 2018, to the following email address: LARA-BMMRLegal@michigan.gov.

Please place “Medical Marihuana Review Panel” in the subject
line.

And any other business properly before the Review Panel.

Next meeting: May 4, 2018

PDF Version

LARA Warns of Fraudulent Medical Marihuana Cease and Desists Letters

LARA Warns of Fraudulent Medical Marihuana Cease and Desists Letters

April 23, 2018 – The Dept. of Licensing and Regulatory Affairs (LARA) and the Bureau of Medical Marihuana Regulation (BMMR) issued a warning today to the public – and to prospective medical marihuana operator license applicants – regarding fraudulent medical marihuana cease and desist letters delivered in the last several days.

The BMMR Enforcement Division and the Michigan State Police are currently conducting a joint investigation into an individual or individuals who have issued fraudulent cease and desist letters at marihuana facility locations – that are currently operating temporarily with local approval – throughout the state. While BMMR has issued over 200 cease and desist letters over the last month, it has not delivered any since April 18, 2018. If a business owner, employee, or applicant has received a cease and desist letter since Thursday, April 19, 2018, they are requested to call the bureau at 517-284-8599.

LARA reminds applicants and potential licensees that BMMR Enforcement Officers carry a form of identification that makes it clear that they work for the bureau. Each ID card has embedded holographic security, the state of Michigan seal, the LARA emblem, and the representative’s name, picture and work title. Please ask the enforcement personnel to show this identification at any time. Also, it should be noted that, moving forward, official communication from the State of Michigan will be delivered either via US Postal mail or in-person hand delivery.

PDF Version